Private Capital Group, LLC Ultragenyx Pharmaceutical Inc. Transaction History
Private Capital Group, LLC
- $133 Million
- Q2 2022
A detailed history of Private Capital Group, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Private Capital Group, LLC holds 206 shares of RARE stock, worth $6,997. This represents 0.01% of its overall portfolio holdings.
Number of Shares
206
Previous 206
-0.0%
Holding current value
$6,997
Previous $15,000
20.0%
% of portfolio
0.01%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RARE
# of Institutions
363Shares Held
88.1MCall Options Held
3.64MPut Options Held
2.24M-
Vanguard Group Inc Valley Forge, PA10.2MShares$347 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$190 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.94MShares$134 Million0.43% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.89MShares$98 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY2.77MShares$94.2 Million1.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.38B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...